Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Net sales	$ 1,735	$ 1,874	$ 5,428	$ 5,774
Cost of products sold	558	680	1,767	1,999
Gross profit	1,177	1,194	3,661	3,775
Operating expenses:
Selling, general and administrative expenses	589	629	1,895	1,866
Research and development expenses	220	229	648	665
Royalty expense	29	36	125	140
Amortization expense	99	97	294	325
Goodwill impairment charge	748		4,350	697
Intangible asset impairment charges	13	9	142	21
Contingent consideration expense	(20)	6	(9)	18
Restructuring charges	54	22	93	77
Litigation-related net charges	50		119
Gain on divestiture	(11)	(8)	(11)	(768)
Operating expenses	1,771	1,020	7,646	3,041
Operating (loss) income	(594)	174	(3,985)	734
Other (expense) income:
Interest expense	(65)	(62)	(197)	(210)
Other, net	(4)	(1)	23	18
(Loss) income before income taxes	(663)	111	(4,159)	542
Income tax (benefit) expense	1	(31)	(30)	208
Net (loss) income	$ (664)	$ 142	$ (4,129)	$ 334
Net (loss) income per common share - basic	$ (0.48)	$ 0.09	$ (2.91)	$ 0.22
Net (loss) income per common share - assuming dilution	$ (0.48)	$ 0.09	$ (2.91)	$ 0.22
Weighted-average shares outstanding
Basic	1,392.5	1,514.4	1,420.3	1,523.1
Assuming dilution	1,392.5	1,524.0	1,420.3	1,532.0